Cite
HARVARD Citation
Cristofanilli, M. et al. (n.d.). LBA2_PROverall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Analyses from PALOMA-3. Annals of oncology. p. . [Online].